Implementation and results of an adverse drug reaction reporting programme at an Indian teaching hospital

Indian Journal of Pharmacology

Volumn 38, Issue 4, 2006, Pages 293-294

  Rao, Padma ^a   Archana, B ^a   Jose, J ^a  

^a MANIPAL COLLEGE OF PHARMACEUTICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANGINA PECTORIS AGENT; ANTIARRHYTHMIC AGENT; ANTIASTHMATIC AGENT; ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; ANTICONVULSIVE AGENT; ANTIDIABETIC AGENT; ANTIFILARIAL AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; ANTIMALARIAL AGENT; ANTIPARKINSON AGENT; ANTITHROMBOCYTIC AGENT; AYURVEDIC DRUG; FIBRINOLYTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; STEROID; UTERUS SPASMOLYTIC AGENT;

ARTICLE; CARDIOVASCULAR DISEASE; CENTRAL NERVOUS SYSTEM DISEASE; DRUG SURVEILLANCE PROGRAM; ENDOCRINE DISEASE; GASTROINTESTINAL SYMPTOM; HEMATOLOGIC DISEASE; HUMAN; INDIA; LIVER DISEASE; METABOLIC DISORDER; MUSCULOSKELETAL DISEASE; RESPIRATORY TRACT DISEASE; SKIN MANIFESTATION; TEACHING HOSPITAL;

EID: 33747607721     PISSN: 02537613     EISSN: None     Source Type: Journal    
DOI: 10.4103/0253-7613.27032     Document Type: Article

References (8)

1. Gholami K, Shalviri G. Factors associated with preventability, predictability, and severity of adverse drug reactions. Ann Pharmacother 1999;33:236-40.
2. Brennan TA, Leape LL, Laird NM, Herbert L, Localio RA, Lawthers AG, et al. Incidence of adverse drug events and negligence in hospitalized patients: results of Harvard Medical Practice Study I. N Engl J Med 1991;324:370-6.
3. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45.
4. Hartwig SC, Siegel J, Schneider PJ. Preventability and severity assessment in reporting adverse drug reactions. Am J Hosp Pharm 1992;49:2229-32.
5. Murphy BM, Frigo LC. Development, implementation, and results of a successful multidisciplinary adverse drug reaction reporting program in a university teaching hospital. Hosp Pharm 1993;28:1199-204.
6. Ramesh M, Pandit J, Parthasarathi G. Adverse drug reactions in a South Indian hospital-their severity and cost involved. Pharmacoepidemiol Drug Safety 2003;12:687-92.
7. Prosser TR, Kamysz PL. Multidisciplinary adverse drug reaction surveillance program. Am J Hosp Pharm 1990;47:1334-9.
8. Suh DC, Woodall BS, Shin SK, Hermes-De-Santis ER. Clinical and economic impact of adverse drug reactions in hospitalized patients. Ann Pharmacother 2000;34:1373-9.